Tag Archives: molecular diagnostics


EQT Agreed to Take QIAGEN Private at €46.50 a Share, Valuing It at About €10.8 Billion:

October 22, 2026 : Permalink

HedgeCo.Net — EQT has agreed to take QIAGEN private through a recommended, all-cash voluntary public takeover offer of €46.50 per share, a transaction the molecular testing company… Continue reading →